Reuters logo
BRIEF-Sophiris Bio Q4 loss per share $0.02
March 27, 2017 / 1:20 PM / 9 months ago

BRIEF-Sophiris Bio Q4 loss per share $0.02

March 27 (Reuters) - Sophiris Bio Inc:

* Sophiris Bio reports fourth quarter and full year 2016 financial results and key corporate highlights

* Q4 loss per share $0.02

* Sophiris Bio Inc - at dec 31, 2016, co had cash, cash equivalents and securities available-for-sale of $29.0 million and working capital of $27.8 million

* Sophiris Bio Inc - expects to receive six-month biopsy data for all patients in late 2017 or early 2018

* Sophiris Bio Inc - expects that its cash and cash equivalents will be sufficient to fund its operations through end of 2018

* Sophiris Bio- not planning on pursuing second phase 3 trial in bph,unless can secure development partner to fund new trial,obtain other financing Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below